2
RESEARCH METHODOLOGY
31
5
MARKET OVERVIEW
Booming breast cancer diagnostics market driven by innovation, early detection demand, and strategic collaborations.
54
5.2.1.1
GROWING INCIDENCE OF BREAST CANCER
5.2.1.2
EXPANSION OF PRIVATE DIAGNOSTIC CHAINS AND IMAGING CENTERS
5.2.1.3
INCREASING DEMAND FOR MINIMALLY INVASIVE AND NON-INVASIVE PROCEDURES
5.2.1.4
GROWING AWARENESS REGARDING EARLY DETECTION OF BREAST CANCER
5.2.1.5
IMPROVED REIMBURSEMENT SCENARIO
5.2.2.1
HIGH COST OF LIQUID BIOPSY TESTS
5.2.2.2
STRINGENT REGULATORY APPROVAL PROCEDURES
5.2.3.1
TECHNOLOGICAL ADVANCEMENTS
5.2.3.2
GROWING COLLABORATION AND FINANCIAL SUPPORT FROM PUBLIC AND PRIVATE SECTORS
5.2.4.1
SHORTAGE OF SKILLED PROFESSIONALS
5.3.1
REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
5.3.2
REGULATORY LANDSCAPE
5.5
SUPPLY CHAIN ANALYSIS
5.5.1
PROMINENT COMPANIES
5.5.2
SMALL & MEDIUM-SIZED ENTERPRISES
5.7.1.2
MAMMOGRAPHY-GUIDED STEREOTACTIC BIOPSY
5.7.1.4
CONTRAST-ENHANCED MAMMOGRAPHY (CEM) GUIDANCE
5.7.2
COMPLEMENTARY TECHNOLOGIES
5.7.2.1
GAMMA-GUIDED BIOPSY SYSTEMS
5.7.2.2
MOLECULAR BREAST IMAGING (MBI)-GUIDED BIOPSY
5.7.3
ADJACENT TECHNOLOGIES
5.7.3.1
SURGICAL ONCOLOGY TECHNOLOGIES
5.7.3.2
CRYOABLATION AND OTHER MINIMALLY INVASIVE ABLATION TECHNOLOGIES
5.10
PORTER’S FIVE FORCES ANALYSIS
5.10.1
THREAT OF NEW ENTRANTS
5.10.2
THREAT OF SUBSTITUTES
5.10.3
BARGAINING POWER OF SUPPLIERS
5.10.4
BARGAINING POWER OF BUYERS
5.10.5
INTENSITY OF COMPETITIVE RIVALRY
5.11.1
AVERAGE SELLING PRICE TREND OF BREAST BIOPSY DEVICES, BY REGION
5.11.2
AVERAGE SELLING PRICE OF BREAST BIOPSY DEVICES, BY APPLICATION
5.12.1
CASE STUDY 1: PET-GUIDED BREAST BIOPSY
5.12.2
CASE STUDY 2: EARLY-STAGE BREAST CANCER AMID COVID PANDEMIC
5.12.3
CASE STUDY 3: SAMPLING MULTIPLE SMALL LESIONS IN DENSE BREAST TISSUE
5.13
KEY CONFERENCES & EVENTS, 2025–2026
5.14
KEY STAKEHOLDERS & BUYING CRITERIA
5.15
IMPACT OF 2025 US TARIFF ON BREAST BIOPSY DEVICES MARKET
5.15.3
PRICE IMPACT ANALYSIS
5.15.4
IMPACT ON COUNTRY/REGION
5.15.5
IMPACT ON END-USE INDUSTRIES
5.16
IMPACT OF GENERATIVE AI/AI ON BREAST BIOPSY DEVICES MARKET
5.17
INVESTMENT & FUNDING SCENARIO
6
BREAST BIOPSY DEVICES MARKET, BY PROCEDURE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 12 Data Tables
92
6.2.1.1
PROCEDURAL ADVANTAGES OF GUIDANCE SYSTEM-BASED BIOPSY TO DRIVE REVENUE GROWTH
6.2.2
VACUUM-ASSISTED BIOPSY (VAB)
6.2.2.1
HIGH DIAGNOSTIC SPECIFICITY AND ACCURACY OF TECHNIQUE TO BOOST DEMAND
6.2.3
FINE NEEDLE ASPIRATION BIOPSY (FNAB)
6.2.3.1
DRAWBACKS ASSOCIATED WITH PROCEDURE TO LIMIT MARKET GROWTH
6.3
OPEN SURGICAL BREAST BIOPSY
6.3.1.1
RISK OF POST-OPERATIVE COMPLICATIONS TO HINDER MARKET GROWTH
6.3.2.1
LONGER RECOVERY PERIOD ASSOCIATED WITH INCISIONAL BIOPSY TO RESTRICT GROWTH
6.4.1
CIRCULATING TUMOR CELLS
6.4.1.1
ABILITY TO PROVIDE IMPORTANT INFORMATION ON MOLECULAR PROPERTIES OF BREAST TUMORS TO BOOST MARKET
6.4.2
CIRCULATING TUMOR DNA (CTDNA)
6.4.2.1
LOW CONCENTRATIONS OF CTDNA TO MAKE SCREENING FOR CLINICALLY RELEVANT MUTATIONS CHALLENGING
7
BREAST BIOPSY DEVICES MARKET, BY PRODUCT
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 21 Data Tables
103
7.2.1.1
EARLY DETECTION THROUGH CORE NEEDLE BIOPSY TO BOOST GROWTH
7.2.2
FINE ASPIRATION NEEDLES
7.2.2.1
ACCURATE CLINICAL DECISIONS FOR EARLY CANCER DIAGNOSIS TO DRIVE DEMAND FOR FINE ASPIRATION NEEDLES
7.2.3
VACUUM-ASSISTED BIOPSY NEEDLES
7.2.3.1
ENHANCED ACCURACY WITH VACUUM-ASSISTED TISSUE SAMPLING TO DRIVE ADOPTION
7.3.1
CORE BIOPSY EQUIPMENT
7.3.1.1
ABILITY TO STREAMLINE BREAST DIAGNOSIS WITH CORE BIOPSY TECHNOLOGY TO BOOST DEMAND
7.3.2
VACUUM-ASSISTED BIOPSY EQUIPMENT
7.3.2.1
ADVANTAGES OF VAB IN BREAST BIOPSY TO DRIVE MARKET GROWTH
7.4.1
MAMMOGRAPHY-GUIDED STEREOTACTIC BIOPSY
7.4.1.1
ADVANTAGES OF TECHNIQUE TO BOOST ADOPTION IN COMING YEARS
7.4.2
ULTRASOUND-GUIDED BIOPSY
7.4.2.1
ABILITY TO CREATE FINE-GRAINED PICTURES OF BREASTS TO DRIVE GROWTH
7.4.3.1
HIGH COST AND LOW SPECIFICITY TO AFFECT DEMAND
7.5.1
GROWING USE OF BIOPSY TABLES TO PERFORM STEREOTACTIC BIOPSY PROCEDURES TO FAVOR MARKET GROWTH
7.6.1
PRODUCT APPROVALS AND LAUNCHES TO DRIVE SEGMENTAL GROWTH
7.7
LIQUID BIOPSY INSTRUMENTS
7.7.1
ONGOING RESEARCH AND CLINICAL TRIALS TO DELIVER NOVEL SOLUTIONS IN MARKET
7.8.1
WIDE USAGE OF LOCALIZATION WIRES TO LOCATE BREAST ABNORMALITIES AND LUMPS TO BOOST MARKET
8
BREAST BIOPSY MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 5 Data Tables
119
8.2
EARLY CANCER SCREENING
8.2.1
GROWING AWARENESS ABOUT EARLY CANCER DETECTION TO DRIVE SEGMENT GROWTH
8.3.1
ABILITY OF PERSONALIZED THERAPY SELECTION TO ENHANCE TREATMENT EFFICACY TO DRIVE DEMAND
8.4.1
GROWING POPULARITY OF REAL-TIME TREATMENT MONITORING TO BOOST MARKET
8.5
RECURRENCE MONITORING
8.5.1
UNMET CLINICAL NEEDS TO CREATE OPPORTUNITIES FOR PLAYERS IN MARKET
9
BREAST BIOPSY DEVICES MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 4 Data Tables
124
9.2.1
RISING DEMAND FOR QUICK AND ACCURATE DIAGNOSIS TO BOOST MARKET
9.3
IMAGING CLINICS & DIAGNOSTIC CENTERS
9.3.1
RISING NUMBER OF PRIVATE IMAGING CENTERS TO CONTRIBUTE TO MARKET GROWTH
9.4.1
INCREASING POPULARITY OF BREAST CARE CENTERS IN DEVELOPED COUNTRIES TO BOOST MARKET
10
BREAST BIOPSY DEVICES MARKET, BY REGION
Comprehensive coverage of 9 Regions with country-level deep-dive of 14 Countries | 125 Data Tables.
129
10.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2.1
US TO DOMINATE NORTH AMERICA BREAST BIOPSY DEVICES MARKET DURING FORECAST PERIOD
10.2.3.1
SURGE IN INCIDENCE OF BREAST CANCER AND FAVORABLE GOVERNMENT GUIDELINES TO SUPPORT MARKET GROWTH
10.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2.1
FAVORABLE CHANGES IN REIMBURSEMENT SCENARIO TO FUEL ADOPTION OF TECHNOLOGICALLY ADVANCED PRODUCTS IN GERMANY
10.3.3.1
INITIATIVES BY PUBLIC & PRIVATE ORGANIZATIONS TO INCREASE AWARENESS ABOUT BREAST CANCER TO DRIVE GROWTH
10.3.4.1
RISING GERIATRIC POPULATION TO SUPPORT MARKET GROWTH
10.3.5.1
EVOLVING REGULATORY SCENARIO FOR BREAST BIOPSY TO BOOST MARKET
10.3.6.1
INCREASED FUNDING SCENARIO TO PROPEL MARKET GROWTH
10.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
10.4.2.1
INCREASING PATIENT POOL AND GOVERNMENT INITIATIVES FOR HEALTHCARE DEVELOPMENT TO FUEL MARKET GROWTH
10.4.3.1
PRESENCE OF UNIVERSAL HEALTHCARE REIMBURSEMENT SCENARIO AND RISING BREAST CANCER CASES
10.4.4.1
GOVERNMENT INITIATIVES TO IMPROVE FEMALE HEALTH TO DRIVE MARKET GROWTH IN INDIA
10.4.5.1
RISING RESEARCH INVESTMENTS AND AWARENESS CAMPAIGNS TO SUPPORT MARKET GROWTH
10.4.6.1
RISING R&D AND PROMISING CLINICAL TRIALS IN COUNTRY TO POSITIVELY IMPACT MARKET GROWTH
10.4.7
REST OF ASIA PACIFIC
10.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
10.5.2.1
KEY MARKET IN LATIN AMERICA OWING TO MODERNIZATION OF HEALTHCARE FACILITIES
10.5.3.1
AVAILABILITY OF ADVANCED CARE AND INCREASING AWARENESS PROGRAMS TO FUEL MARKET GROWTH
10.5.4
REST OF LATIN AMERICA
10.6
MIDDLE EAST & AFRICA
10.6.1
IMPROVING HEALTHCARE INFRASTRUCTURE AND INCREASING PUBLIC–PRIVATE INVESTMENTS TO DRIVE MARKET GROWTH IN MEA REGION
10.6.2
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
10.6.3.1
GROWING HEALTHCARE INFRASTRUCTURE TO FUEL MARKET GROWTH
10.6.4
REST OF MIDDLE EAST & AFRICA
11
COMPETITIVE LANDSCAPE
Uncover how key players and startups shape market dynamics through strategic positioning and financial prowess.
202
11.2
KEY PLAYER STRATEGY/RIGHT TO WIN
11.2.1
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS
11.3
REVENUE ANALYSIS, 2020–2024
11.4
MARKET SHARE ANALYSIS, 2024
11.5
COMPANY EVALUATION MATRIX: KEY PLAYERS (2024)
11.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.5.5.1
COMPANY FOOTPRINT
11.5.5.2
REGION FOOTPRINT
11.5.5.3
PRODUCT FOOTPRINT
11.5.5.4
PROCEDURE FOOTPRINT
11.5.5.5
APPLICATION FOOTPRINT
11.5.5.6
END-USER FOOTPRINT
11.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES (2024)
11.6.1
PROGRESSIVE COMPANIES
11.6.2
RESPONSIVE COMPANIES
11.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
11.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
11.6.5.2
COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS, BY REGION
11.6.5.3
COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS, PRODUCT
11.7
COMPANY VALUATION & FINANCIAL METRICS
11.8
BRAND/PRODUCT COMPARISON
11.9
COMPETITIVE SCENARIO
11.9.1
THIS SEGMENT INCLUDES THE GROWTH STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE BREAST BIOPSY DEVICES MARKET BETWEEN JANUARY 2020 AND MAY 2025.
11.9.2
PRODUCT LAUNCHES & APPROVALS
12
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
224
12.1.1.1
BUSINESS OVERVIEW
12.1.1.2
PRODUCTS OFFERED
12.1.2
DANAHER CORPORATION
12.1.3
BECTON, DICKINSON AND COMPANY
12.1.6
MERIT MEDICAL SYSTEMS
12.1.7
MENARINI SILICON BIOSYSTEMS SPA
12.1.8
GUARDANT HEALTH, INC.
12.1.9
NEOGENOMICS LABORATORIES, INC.
12.1.12
BIO-RAD LABORATORIES, INC.
12.1.13
F. HOFFMANN-LA ROCHE LTD.
12.1.14
EXACT SCIENCES CORPORATION
12.1.15
SYSMEX INOSTICS (A SUBSIDIARY OF SYSMEX CORPORATION)
12.1.16
THERMO FISHER SCIENTIFIC
12.1.17
FUJIFILM HOLDINGS CORPORATION
12.2.1
CARDIFF ONCOLOGY INC.
12.2.2
MYRIAD GENETICS, INC.
12.2.4
FLUXION BIOSCIENCES, INC.
12.2.6
IZI MEDICAL PRODUCTS
12.2.7
REMINGTON MEDICAL INC.
13.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3
CUSTOMIZATION OPTIONS
TABLE 1
BREAST BIOPSY DEVICES MARKET: STUDY ASSUMPTIONS
TABLE 2
BREAST BIOPSY DEVICES MARKET: RISK ANALYSIS
TABLE 3
MEDICARE REIMBURSEMENT FOR BREAST BIOPSY
TABLE 4
COST AND UTILITY MODEL INPUTS (2022)
TABLE 5
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 6
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9
MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10
US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 11
US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
TABLE 12
CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
TABLE 13
JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
TABLE 14
CHINA: CLASSIFICATION OF MEDICAL DEVICES
TABLE 15
BREAST BIOPSY DEVICES MARKET: ROLE IN ECOSYSTEM
TABLE 16
IMPORT DATA FOR NEEDLES, CATHETERS, AND CANNULAE (HS CODE 901839), BY COUNTRY, 2020–2024 (USD THOUSAND)
TABLE 17
EXPORT DATA FOR BREAST BIOPSY DEVICES (HS CODE 901839), BY COUNTRY, 2020–2024 (USD THOUSAND)
TABLE 18
BREAST BIOPSY DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 19
INDICATIVE SELLING PRICE TREND OF BREAST BIOPSY DEVICES, BY REGION, 2022–2024 (USD)
TABLE 20
AVERAGE SELLING PRICE OF BREAST BIOPSY DEVICES, BY KEY PLAYER, 2024 (USD)
TABLE 21
BREAST BIOPSY DEVICES MARKET: LIST OF MAJOR CONFERENCES & EVENTS
TABLE 22
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BREAST BIOPSY DEVICES, BY TOP THREE END USERS
TABLE 23
KEY BUYING CRITERIA FOR TOP THREE END USERS OF BREAST BIOPSY DEVICES
TABLE 24
US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 25
BREAST BIOPSY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 26
NEEDLE BREAST BIOPSY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 27
CORE NEEDLE BIOPSY DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 28
VACUUM-ASSISTED BIOPSY DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 29
FINE NEEDLE ASPIRATION BIOPSY DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 30
OPEN SURGICAL BREAST BIOPSY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 31
EXCISIONAL BIOPSY DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 32
INCISIONAL BIOPSY DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 33
LIQUID BREAST BIOPSY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 34
LIQUID BREAST BIOPSY DEVICES MARKET FOR CIRCULATING TUMOR CELLS, BY REGION, 2023–2030 (USD MILLION)
TABLE 35
LIQUID BREAST BIOPSY DEVICES MARKET FOR CIRCULATING TUMOR DNA, BY REGION, 2023–2030 (USD MILLION)
TABLE 36
LIQUID BREAST BIOPSY DEVICES MARKET FOR OTHER BIOMARKERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 37
BREAST BIOPSY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 38
BREAST BIOPSY DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 39
BREAST BIOPSY DEVICES MARKET FOR BIOPSY NEEDLES, BY REGION, 2023–2030 (USD MILLION)
TABLE 40
BREAST BIOPSY DEVICES MARKET FOR BIOPSY NEEDLES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 41
BREAST BIOPSY DEVICES MARKET FOR CORE NEEDLES, BY REGION, 2023–2030 (USD MILLION)
TABLE 42
BREAST BIOPSY DEVICES MARKET FOR FINE ASPIRATION NEEDLES, BY REGION, 2023–2030 (USD MILLION)
TABLE 43
BREAST BIOPSY DEVICES MARKET FOR VACUUM-ASSISTED NEEDLES, BY REGION, 2023–2030 (USD MILLION)
TABLE 44
BREAST BIOPSY DEVICES MARKET FOR BIOPSY EQUIPMENT, BY REGION, 2023–2030 (USD MILLION)
TABLE 45
BREAST BIOPSY DEVICES MARKET FOR BIOPSY EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 46
BREAST BIOPSY DEVICES MARKET FOR CORE BIOPSY EQUIPMENT, BY REGION, 2023–2030 (USD MILLION)
TABLE 47
BREAST BIOPSY DEVICES MARKET FOR VACUUM-ASSISTED BIOPSY EQUIPMENT, BY REGION, 2023–2030 (USD MILLION)
TABLE 48
BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY REGION, 2023–2030 (USD MILLION)
TABLE 49
BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 50
BREAST BIOPSY DEVICES MARKET FOR MAMMOGRAPHY-GUIDED STEREOTACTIC BIOPSY, BY REGION, 2023–2030 (USD MILLION)
TABLE 51
BREAST BIOPSY DEVICES MARKET FOR ULTRASOUND-GUIDED BIOPSY, BY REGION, 2023–2030 (USD MILLION)
TABLE 52
BREAST BIOPSY DEVICES MARKET FOR MRI-GUIDED BIOPSY, BY REGION, 2023–2030 (USD MILLION)
TABLE 53
BREAST BIOPSY DEVICES MARKET FOR BIOPSY TABLES, BY REGION, 2023–2030 (USD MILLION)
TABLE 54
BREAST BIOPSY DEVICES MARKET FOR ASSAY KITS, BY REGION, 2023–2030 (USD MILLION)
TABLE 55
BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY INSTRUMENTS, BY REGION, 2023–2030 (USD MILLION)
TABLE 56
BREAST BIOPSY DEVICES MARKET FOR LOCALIZATION WIRES, BY REGION, 2023–2030 (USD MILLION)
TABLE 57
BREAST BIOPSY DEVICES MARKET FOR OTHER PRODUCTS, BY REGION, 2023–2030 (USD MILLION)
TABLE 58
BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 59
BREAST BIOPSY DEVICES MARKET FOR EARLY CANCER SCREENING, BY REGION, 2023–2030 (USD MILLION)
TABLE 60
BREAST BIOPSY DEVICES MARKET FOR THERAPY SELECTION, BY REGION, 2023–2030 (USD MILLION)
TABLE 61
BREAST BIOPSY DEVICES MARKET FOR TREATMENT MONITORING, BY REGION, 2023–2030 (USD MILLION)
TABLE 62
BREAST BIOPSY DEVICES MARKET FOR RECURRENCE MONITORING, BY REGION, 2023–2030 (USD MILLION)
TABLE 63
BREAST BIOPSY DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 64
BREAST BIOPSY DEVICES MARKET FOR HOSPITALS & CLINICS, BY REGION, 2023–2030 (USD MILLION)
TABLE 65
BREAST BIOPSY DEVICES MARKET FOR IMAGING CLINICS & DIAGNOSTIC CENTERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 66
BREAST BIOPSY DEVICES MARKET FOR BREAST CARE CENTERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 67
BREAST BIOPSY DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 68
TOTAL NUMBER OF BREAST BIOPSY PROCEDURES BY REGION, 2024
TABLE 69
VACCUM ASSISTED BIOPSY NEEDLES MARKET, REGION, 2023–2030 (USD MILLION)
TABLE 70
NA BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 71
NORTH AMERICA: MACROINDICATORS
TABLE 72
NORTH AMERICA: BREAST BIOPSY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 73
NORTH AMERICA: BREAST BIOPSY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 74
NORTH AMERICA: BREAST BIOPSY DEVICES MARKET, BY PROCEDURE, 2023–2030 (USD MILLION)
TABLE 75
NORTH AMERICA: NEEDLE BREAST BIOPSY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 76
NORTH AMERICA: BREAST BIOPSY DEVICES MARKET FOR BIOPSY EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 77
NORTH AMERICA: BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 78
NORTH AMERICA: BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 79
NORTH AMERICA: BREAST BIOPSY DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 80
US: BREAST BIOPSY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 81
US: NEEDLE BREAST BIOPSY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 82
US: BREAST BIOPSY DEVICES MARKET FOR BIOPSY EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 83
US: BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 84
CANADA: BREAST BIOPSY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 85
CANDA: NEEDLE BREAST BIOPSY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 86
CANADA: BREAST BIOPSY DEVICES MARKET FOR BIOPSY EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 87
CANADA: BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 88
EUROPE: MACROINDICATORS
TABLE 89
EUROPE: BREAST BIOPSY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 90
EUROPE: BREAST BIOPSY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 91
EUROPE: BREAST BIOPSY DEVICES MARKET, BY PROCEDURE, 2023–2030 (USD MILLION)
TABLE 92
EUROPE: NEEDLE BREAST BIOPSY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 93
EUROPE: BREAST BIOPSY DEVICES MARKET FOR BIOPSY EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 94
EUROPE: BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 95
EUROPE: BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 96
EUROPE: BREAST BIOPSY DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 97
GERMANY: BREAST BIOPSY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 98
GERMANY: NEEDLE BREAST BIOPSY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 99
GERMANY: BREAST BIOPSY DEVICES MARKET FOR BIOPSY EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 100
GERMANY: BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 101
UK: BREAST BIOPSY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 102
UK: NEEDLE BREAST BIOPSY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 103
UK: BREAST BIOPSY DEVICES MARKET FOR BIOPSY EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 104
UK: BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 105
FRANCE: BREAST BIOPSY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 106
FRANCE: NEEDLE BREAST BIOPSY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 107
FRANCE: BREAST BIOPSY DEVICES MARKET FOR BIOPSY EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 108
FRANCE: BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 109
ITALY: BREAST BIOPSY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 110
ITALY: NEEDLE BREAST BIOPSY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 111
ITALY BREAST BIOPSY DEVICES MARKET FOR BIOPSY EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 112
ITALY: BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 113
SPAIN: BREAST BIOPSY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 114
SPAIN: NEEDLE BREAST BIOPSY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 115
SPAIN: BREAST BIOPSY DEVICES MARKET FOR BIOPSY EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 116
SPAIN: BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 117
REST OF EUROPE: BREAST BIOPSY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 118
REST OF EUROPE: NEEDLE BREAST BIOPSY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 119
REST OF EUROPE: BREAST BIOPSY DEVICES MARKET FOR BIOPSY EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 120
REST OF EUROPE: BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 121
ASIA PACIFIC: MACROINDICATORS
TABLE 122
ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 123
ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 124
ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY PROCEDURE, 2023–2030 (USD MILLION)
TABLE 125
ASIA PACIFIC: NEEDLE BREAST BIOPSY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 126
ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET FOR BIOPSY EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 127
ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 128
ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 129
ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 130
CHINA: BREAST BIOPSY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 131
CHINA: NEEDLE BREAST BIOPSY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 132
CHINA: BREAST BIOPSY DEVICES MARKET FOR BIOPSY EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 133
CHINA: BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 134
JAPAN: BREAST BIOPSY DEVICES MARKET, BY PRODUCT, 2023–2030
TABLE 135
JAPAN: NEEDLE BREAST BIOPSY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 136
JAPAN: BREAST BIOPSY DEVICES MARKET FOR BIOPSY EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 137
JAPAN: BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 138
INDIA: BREAST BIOPSY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 139
INDIA: NEEDLE BREAST BIOPSY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 140
INDIA: BREAST BIOPSY DEVICES MARKET FOR BIOPSY EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 141
INDIA: BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 142
AUSTRALIA: BREAST BIOPSY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 143
AUSTRALIA: NEEDLE BREAST BIOPSY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 144
AUSTRALIA: BREAST BIOPSY DEVICES MARKET FOR BIOPSY EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 145
AUSTRALIA: BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 146
SOUTH KOREA: BREAST BIOPSY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 147
SOUTH KOREA: NEEDLE BREAST BIOPSY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 148
SOUTH KOREA: BREAST BIOPSY DEVICES MARKET FOR BIOPSY EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 149
SOUTH KOREA: BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 150
REST OF ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 151
REST OF ASIA PACIFIC: NEEDLE BREAST BIOPSY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 152
REST OF ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET FOR BIOPSY EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 153
REST OF ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 154
LATIN AMERICA: MACROINDICATORS
TABLE 155
LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 156
LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 157
LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY PROCEDURE, 2023–2030 (USD MILLION)
TABLE 158
LATIN AMERICA: NEEDLE BREAST BIOPSY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 159
LATIN AMERICA: BREAST BIOPSY DEVICES MARKET FOR BIOPSY EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 160
LATIN AMERICA: BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 161
LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 162
LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 163
BRAZIL: BREAST BIOPSY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 164
BRAZIL: NEEDLE BREAST BIOPSY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 165
BRAZIL: BREAST BIOPSY DEVICES MARKET FOR BIOPSY EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 166
BRAZIL: BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 167
MEXICO: BREAST BIOPSY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 168
MEXICO: NEEDLE BREAST BIOPSY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 169
MEXICO: BREAST BIOPSY DEVICES MARKET FOR BIOPSY EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 170
MEXICO: BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 171
REST OF LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 172
REST OF LATIN AMERICA: NEEDLE BREAST BIOPSY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 173
REST OF LATIN AMERICA: BREAST BIOPSY DEVICES MARKET FOR BIOPSY EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 174
REST OF LATIN AMERICA: BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 175
MIDDLE EAST & AFRICA: KEY MACROINDICATORS
TABLE 176
MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 177
MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 178
MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET, BY PROCEDURE, 2023–2030 (USD MILLION)
TABLE 179
MIDDLE EAST & AFRICA: NEEDLE BREAST BIOPSY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 180
MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET FOR BIOPSY EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 181
MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 182
MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 183
MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 184
GCC COUNTRIES: BREAST BIOPSY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 185
GCC COUNTRIES: NEEDLE BREAST BIOPSY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 186
GCC COUNTRIES: BREAST BIOPSY DEVICES MARKET FOR BIOPSY EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 187
GCC COUNTRIES: BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 188
REST OF MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 189
REST OF MIDDLE EAST & AFRICA: NEEDLE BREAST BIOPSY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 190
REST OF MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET FOR BIOPSY EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 191
REST OF MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 192
OVERVIEW OF STRATEGIES DEPLOYED BY KEY BREAST BIOPSY DEVICE MANUFACTURING COMPANIES
TABLE 193
BREAST BIOPSY DEVICES MARKET: DEGREE OF COMPETITION
TABLE 194
BREAST BIOPSY DEVICES MARKET: REGION FOOTPRINT
TABLE 195
BREAST BIOPSY DEVICES MARKET: PRODUCT FOOTPRINT
TABLE 196
BREAST BIOPSY DEVICES MARKET: PROCEDURE FOOTPRINT
TABLE 197
BREAST BIOPSY DEVICES MARKET: APPLICATION FOOTPRINT
TABLE 198
BREAST BIOPSY DEVICES MARKET: END USER FOOTPRINT
TABLE 199
BREAST BIOPSY DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 200
BREAST BIOPSY DEVICES MARKET: COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS, BY REGION
TABLE 201
BREAST BIOPSY DEVICES MARKET: COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS, BY PRODUCT
TABLE 202
BREAST BIOPSY DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2025
TABLE 203
BREAST BIOPSY DEVICES MARKET: DEALS, JANUARY 2021–MAY 2025
TABLE 204
HOLOGIC, INC. BUSINESS OVERVIEW
TABLE 205
HOLOGIC, INC.: PRODUCTS OFFERED
TABLE 206
HOLOGIC, INC.: DEALS, JANUARY 2021–MAY 2025
TABLE 207
DANAHER CORPORATION: COMPANY OVERVIEW
TABLE 208
DANAHER CORPORATION: PRODUCTS OFFERED
TABLE 209
DANAHER CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2025
TABLE 210
DANAHER CORPORATION: DEALS, JANUARY 2021–MAY 2025
TABLE 211
BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
TABLE 212
BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
TABLE 213
ARGON MEDICAL: COMPANY OVERVIEW
TABLE 214
ARGON MEDICAL: PRODUCTS OFFERED
TABLE 215
ARGON MEDICAL: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2025
TABLE 216
ARGON MEDICAL: DEALS, JANUARY 2021–MAY 2025
TABLE 217
QIAGEN: COMPANY OVERVIEW
TABLE 218
QIAGEN: PRODUCTS OFFERED
TABLE 219
QIAGEN: DEALS, JANUARY 2021–MAY 2025
TABLE 220
MERIT MEDICAL SYSTEMS: COMPANY OVERVIEW
TABLE 221
MERIT MEDICAL SYSTEMS: PRODUCTS OFFERED
TABLE 222
MERIT MEDICAL SYSTEMS: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2025
TABLE 223
MERIT MEDICAL SYSTEMS: DEALS, JANUARY 2021–MAY 2025
TABLE 224
MENARINI SILICON BIOSYSTEMS SPA: COMPANY OVERVIEW
TABLE 225
MENARINI SILICON BIOSYSTEMS SPA: PRODUCTS OFFERED
TABLE 226
MENARINI SILICON BIOSYSTEMS SPA: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2025
TABLE 227
MENARINI SILICON BIOSYSTEMS SPA: DEALS, JANUARY 2021–MAY 2025
TABLE 228
GUARDANT HEALTH, INC.: COMPANY OVERVIEW
TABLE 229
GUARDANT HEALTH, INC.: PRODUCTS OFFERED
TABLE 230
GUARDANT HEALTH, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2025
TABLE 231
GUARDANT HEALTH, INC.: DEALS, JANUARY 2021–MAY 2025
TABLE 232
GUARDANT HEALTH, INC.: OTHER DEVELOPMENTS, JANUARY 2021–MAY 2025
TABLE 233
NEOGENOMICS LABORATORIES, INC.: COMPANY OVERVIEW
TABLE 234
NEOGENOMICS LABORATORIES, INC.: PRODUCTS OFFERED
TABLE 235
NEOGENOMICS LABORATORIES, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2025
TABLE 236
NEOGENOMICS LABORATORIES, INC.: DEALS, JANUARY 2021–MAY 2025
TABLE 237
STERYLAB S.R.L: COMPANY OVERVIEW
TABLE 238
STERYLAB S.R.L: PRODUCTS OFFERED
TABLE 239
BIOCEPT, INC.: COMPANY OVERVIEW
TABLE 240
BIOCEPT, INC.: PRODUCTS OFFERED
TABLE 241
BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
TABLE 242
BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED
TABLE 243
BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2025
TABLE 244
F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
TABLE 245
F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED
TABLE 246
EXACT SCIENCES CORPORATION: COMPANY OVERVIEW
TABLE 247
EXACT SCIENCES CORPORATION: PRODUCTS OFFERED
TABLE 248
EXACT SCIENCES CORPORATION: DEALS, JANUARY 2021–MAY 2025
TABLE 249
SYSMEX INOSTICS: COMPANY OVERVIEW
TABLE 250
SYSMEX INOSTICS: PRODUCTS OFFERED
TABLE 251
SYSMEX INOSTICS: DEALS, JANUARY 2021–MAY 2025
TABLE 252
THERMO FISHER SCIENTIFIC: COMPANY OVERVIEW
TABLE 253
THERMO FISHER SCIENTIFIC: PRODUCTS OFFERED
TABLE 254
THERMO FISHER SCIENTIFIC: DEALS, JANUARY 2021–MARCH 2024
TABLE 255
FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW
TABLE 256
FUJIFILM HOLDINGS CORPORATION: PRODUCTS OFFERED
TABLE 257
CARDIFF ONCOLOGY INC.: COMPANY OVERVIEW
TABLE 258
MYRIAD GENETICS, INC.: COMPANY OVERVIEW
TABLE 259
ILLUMINA, INC.: COMPANY OVERVIEW
TABLE 260
FLUXION BIOSCIENCES, INC.: COMPANY OVERVIEW
TABLE 261
INRAD, INC.: COMPANY OVERVIEW
TABLE 262
IZI MEDICAL PRODUCTS: COMPANY OVERVIEW
TABLE 263
REMINGTON MEDICAL INC.: COMPANY OVERVIEW
TABLE 264
CP MEDICAL: COMPANY OVERVIEW
FIGURE 1
BREAST BIOPSY DEVICES MARKET SEGMENTATION & REGIONAL SCOPE
FIGURE 2
BREAST BIOPSY DEVICES MARKET: RESEARCH DATA
FIGURE 3
BREAST BIOPSY DEVICES MARKET: RESEARCH DESIGN
FIGURE 4
BREAST BIOPSY DEVICES MARKET: KEY DATA FROM SECONDARY SOURCES
FIGURE 5
BREAST BIOPSY DEVICES MARKET: PRIMARY SOURCES
FIGURE 6
BREAST BIOPSY DEVICES MARKET: KEY INDUSTRY INSIGHTS
FIGURE 7
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 8
BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
FIGURE 9
RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 10
BREAST BIOPSY DEVICES MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH (REVENUE SHARE ANALYSIS)
FIGURE 11
BREAST BIOPSY DEVICES MARKET SIZE ESTIMATION: COMPANY REVENUE ESTIMATION
FIGURE 12
BREAST BIOPSY DEVICES MARKET: TOP-DOWN APPROACH
FIGURE 13
CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 14
BREAST BIOPSY DEVICES MARKET: DATA TRIANGULATION
FIGURE 15
BREAST BIOPSY DEVICES MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
FIGURE 16
BREAST BIOPSY DEVICES MARKET, BY PROCEDURE, 2025 VS. 2030 (USD MILLION)
FIGURE 17
BREAST BIOPSY PROCEDURE GROWTH [ BIOPSY PROCEDURES IN ‘000S VS FEMALES AGED 40 – 69 YEARS IN MILLIONS (2023) ]
FIGURE 18
BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
FIGURE 19
BREAST BIOPSY DEVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 20
BREAST BIOPSY DEVICES MARKET: REGIONAL SNAPSHOT
FIGURE 21
GROWING INCIDENCE OF BREAST CANCER TO DRIVE MARKET
FIGURE 22
NORTH AMERICA TO ACCOUNT FOR LARGEST SHARE OF MARKET DURING FORECAST PERIOD
FIGURE 23
EARLY CANCER SCREENING SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2024
FIGURE 24
CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 25
BREAST BIOPSY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 26
VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE
FIGURE 27
BREAST BIOPSY DEVICES MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 28
BREAST BIOPSY DEVICES MARKET: ECOSYSTEM ANALYSIS
FIGURE 29
PATENT DETAILS FOR BREAST BIOPSY DEVICES (JANUARY 2013–MAY 2025)
FIGURE 30
BREAST BIOPSY DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 31
AVERAGE SELLING PRICE TREND OF BREAST BIOPSY DEVICES, BY REGION, 2022–2024 (USD)
FIGURE 32
AVERAGE SELLING PRICE OF BREAST BIOPSY DEVICES, BY KEY PLAYER, 2024 (USD)
FIGURE 33
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BREAST BIOPSY DEVICES, BY TOP THREE END USERS
FIGURE 34
KEY BUYING CRITERIA FOR TOP THREE END USERS OF BREAST BIOPSY DEVICES
FIGURE 35
BREAST BIOPSY DEVICES: INVESTMENT & FUNDING SCENARIO
FIGURE 36
NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023
FIGURE 37
VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2018–2022 (USD MILLION)
FIGURE 38
NORTH AMERICA: BREAST BIOPSY DEVICES MARKET SNAPSHOT
FIGURE 39
ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET SNAPSHOT
FIGURE 40
REVENUE ANALYSIS OF TOP 5 PLAYERS IN BREAST BIOPSY DEVICES MARKET, 2020–2024
FIGURE 41
MARKET SHARE ANALYSIS OF KEY PLAYERS IN BREAST BIOPSY DEVICES MARKET (2024)
FIGURE 42
BREAST BIOPSY DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 43
BREAST BIOPSY DEVICES MARKET: COMPANY FOOTPRINT
FIGURE 44
BREAST BIOPSY DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 45
EV/EBITDA OF KEY VENDORS
FIGURE 46
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 47
BREAST BIOPSY DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 48
HOLOGIC, INC.: COMPANY SNAPSHOT (2024)
FIGURE 49
DANAHER CORPORATION: COMPANY SNAPSHOT (2024)
FIGURE 50
BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2024)
FIGURE 51
QIAGEN: COMPANY SNAPSHOT (2024)
FIGURE 52
MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2024)
FIGURE 53
GUARDANT HEALTH, INC.: COMPANY SNAPSHOT (2024)
FIGURE 54
NEOGENOMICS LABORATORIES, INC.: COMPANY SNAPSHOT (2023)
FIGURE 55
BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024)
FIGURE 56
F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2024)
FIGURE 57
EXACT SCIENCES CORPORATION: COMPANY SNAPSHOT (2024)
FIGURE 58
SYSMEX INOSTICS: COMPANY SNAPSHOT (2024)
FIGURE 59
THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2024)
FIGURE 60
FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2024)
Growth opportunities and latent adjacency in Breast Biopsy Devices Market